Literature DB >> 12205473

ATM heterozygosity and cancer risk.

Patrick Concannon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12205473     DOI: 10.1038/ng0902-89

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  11 in total

1.  ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.

Authors:  Mahnoush Babaei; Midori Mitui; Eric R Olson; Richard A Gatti
Journal:  Hum Genet       Date:  2005-04-21       Impact factor: 4.132

2.  Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  Shareef A Nahas; Anthony W Butch; Liutao Du; Richard A Gatti
Journal:  Clin Chem       Date:  2009-01-15       Impact factor: 8.327

3.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 4.  ATM and ATR: sensing DNA damage.

Authors:  Jun Yang; Zheng-Ping Xu; Yun Huang; Hope E Hamrick; Penelope J Duerksen-Hughes; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

5.  Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

Authors:  M Mitui; S A Nahas; L T Du; Z Yang; C H Lai; K Nakamura; S Arroyo; S Scott; A Purayidom; P Concannon; M Lavin; R A Gatti
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

Review 6.  Cancer genetics, precision prevention and a call to action.

Authors:  Clare Turnbull; Amit Sud; Richard S Houlston
Journal:  Nat Genet       Date:  2018-08-29       Impact factor: 38.330

7.  Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.

Authors:  Kristjana Einarsdóttir; Lena U Rosenberg; Keith Humphreys; Carine Bonnard; Juni Palmgren; Yuqing Li; Yi Li; Kee S Chia; Edison T Liu; Per Hall; Jianjun Liu; Sara Wedrén
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

8.  Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.

Authors:  Seiichi Umesako; Kae Fujisawa; Sayoko Iiga; Nobuko Mori; Masahiro Takahashi; Doo-Pyo Hong; Chang-Woo Song; Satomi Haga; Syunsuke Imai; Otsura Niwa; Masaaki Okumoto
Journal:  Breast Cancer Res       Date:  2004-12-10       Impact factor: 6.466

Review 9.  Radiation and breast cancer: a review of current evidence.

Authors:  Cécile M Ronckers; Christine A Erdmann; Charles E Land
Journal:  Breast Cancer Res       Date:  2004-11-23       Impact factor: 6.466

Review 10.  Synchronous invasive ductal carcinoma and intravascular large B-cell lymphoma of the breast: a case report and review of the literature.

Authors:  Christopher Wei Guang Ho; Sangeeta Mantoo; Chin Hong Lim; Chow Yin Wong
Journal:  World J Surg Oncol       Date:  2014-04-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.